Marksans Pharma surges on inking pact to acquire 100% stake in ABCnow GmbH
Marksans Pharma is currently trading at Rs. 267.60, up by 6.55 points or 2.51% from its previous closing of Rs. 261.05 on the BSE.
The scrip opened at Rs. 262.65 and has touched a high and low of Rs. 272.40 and Rs. 259.50 respectively. So far 125545 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 278.20 on 01-Jul-2026 and a 52 week low of Rs. 156.00 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 273.55 and Rs. 257.55 respectively. The current market cap of the company is Rs. 12,108.54 crore.
The promoters holding in the company stood at 43.87%, while Institutions and Non-Institutions held 23.33% and 32.79% respectively.
Marksans Pharma has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH, a Germany based pharmaceutical company with frontend sales, marketing, and distribution capabilities across German healthcare market. The company will acquire entire shareholding of ABCnow GmbH for a total consideration of 892,384 euro. The acquisition is expected to be completed by July 31, 2026.
This acquisition will enable the company to use the front-end sales and marketing infrastructure of ABCnow GmbH for marketing its products manufactured in India, UK, and USA regions. It will bolster the company’s presence in the European markets.
The acquisition marks a strategic step in expanding the company’s presence across regulated European markets and strengthening its forward-integration strategy through direct, owned market-access capabilities in the European Union.
